Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes

Clinical trial NCT00098683 · COMPLETED

Trial details

NCT number: NCT00098683
Sponsor: Children's Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms

Start date: 2005-01-01
Primary completion: 2007-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.